Fiduciary Alliance LLC Reduces Position in UnitedHealth Group Incorporated $UNH

Fiduciary Alliance LLC reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.7% in the third quarter, according to its most recent filing with the SEC. The fund owned 12,110 shares of the healthcare conglomerate’s stock after selling 2,082 shares during the period. Fiduciary Alliance LLC’s holdings in UnitedHealth Group were worth $4,182,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Legacy Private Trust Co. lifted its holdings in UnitedHealth Group by 37.4% during the 3rd quarter. Legacy Private Trust Co. now owns 14,825 shares of the healthcare conglomerate’s stock valued at $5,119,000 after buying an additional 4,033 shares in the last quarter. Wedmont Private Capital raised its stake in shares of UnitedHealth Group by 36.4% during the third quarter. Wedmont Private Capital now owns 15,040 shares of the healthcare conglomerate’s stock valued at $5,469,000 after acquiring an additional 4,011 shares in the last quarter. Czech National Bank grew its stake in UnitedHealth Group by 3.7% in the third quarter. Czech National Bank now owns 230,023 shares of the healthcare conglomerate’s stock worth $79,427,000 after purchasing an additional 8,297 shares in the last quarter. Ignite Planners LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at $398,000. Finally, Balefire LLC increased its stake in shares of UnitedHealth Group by 203.4% during the third quarter. Balefire LLC now owns 3,608 shares of the healthcare conglomerate’s stock valued at $1,246,000 after buying an additional 2,419 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $331.60 on Thursday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $606.36. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. The company has a market cap of $300.38 billion, a PE ratio of 17.31, a P/E/G ratio of 2.18 and a beta of 0.43. The business has a 50-day simple moving average of $338.14 and a two-hundred day simple moving average of $317.84.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same period last year, the business earned $7.15 EPS. UnitedHealth Group’s revenue for the quarter was up 12.2% on a year-over-year basis. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were paid a $2.21 dividend. The ex-dividend date was Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price on the stock. in a report on Wednesday, October 29th. KeyCorp lifted their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. Bank of America increased their target price on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Wednesday, October 8th. TD Cowen upped their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research note on Thursday, October 30th. Finally, The Goldman Sachs Group started coverage on shares of UnitedHealth Group in a report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 target price for the company. Seventeen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Hold” and a consensus price target of $385.54.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.